SCHEMBL1930652

SCHEMBL1930652

Cc1ccc(NC(=O)C(CC2CCCC2)n2cc(C(F)(F)F)ccc2=O)nc1

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1930651 1.00 GCK (0.66) GCK
SCHEMBL1929834 0.93 GCK (0.66) GCK
SCHEMBL1929828 0.93 GCK (0.66) GCK
SCHEMBL1829271 0.92 GCK (0.62) GCK
SCHEMBL1829276 0.92 GCK (0.62) GCK
SCHEMBL1931583 0.90 GCK (0.60) GCK
SCHEMBL1931580 0.90 GCK (0.60) GCK
SCHEMBL1830398 0.88 GCK (0.57) GCK
SCHEMBL1830405 0.88 GCK (0.57) GCK
SCHEMBL1829779 0.88 GCK (0.67) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110130365-A1 Fluorinated Heteroaryls BENBOW JOHN W 2011-06-02 US claimed
US-20110130365-A1 Fluorinated Heteroaryls BENBOW JOHN W 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110130365-A1 Fluorinated Heteroaryls GCKR, GALK1, GCK GCK 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.